Skip to content
PoliticalRepoPoliticalRepo

United States · Bill · HR

H.R. 6640 (116th)

Medicare Advantage COVID Treatment Act

referredUnited States· United States Congress· EN

Introduced

28 April 2020

Last action

28 April 2020 · Introduced

Status

Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Sponsors

Rep. Mucarsel-Powell, Debbie [D-FL-26], Rep. Kind, Ron [D-WI-3], Rep. Cohen, Steve [D-TN-9], Rep. Wilson, Frederica S. [D-FL-24], Rep. Kilmer, Derek [D-WA-6], Rep. Jackson Lee, Sheila [D-TX-18], Rep. Hayes, Jahana [D-CT-5], Rep. Axne, Cynthia [D-IA-3], Rep. Morelle, Joseph D. [D-NY-25], Rep. Cisneros, Gilbert Ray [D-CA-31], Rep. Moore, Gwen [D-WI-4], Rep. Watson Coleman, Bonnie [D-NJ-12]

Subjects

Healthcare

Source updated

3 January 2025

Healthcare

Official sourceDownload fileView documentsShare

Summary

Medicare Advantage COVID Treatment Act This bill requires Medicare Advantage (MA) plans to cover specified treatment services relating to COVID-19 (i.e., coronavirus disease 2019) without cost-sharing during the public health emergency declared on January 31, 2020. The CMS must reimburse MA plans for cost-sharing amounts that would otherwise have been received, in accordance with a specified timeline. MA plans are also prohibited from instituting prior authorization or other utilization management requirements with respect to coverage of specified critical treatment services (e.g., ventilator services and intensive care unit services).

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 28 April 2020

    Introduced

    Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    Source: IntroReferral

  2. 28 April 2020

    Introduced

    Introduced in House

    Source: IntroReferral

  3. 28 April 2020

    Introduced

    Introduced in House

    Source: IntroReferral

Votes

No vote records are attached yet.

Versions

Documents

3 official files

Introduced in House (text)

View fileDownload file

This file cannot be previewed here. Use View or Download.

Leesvertaling

Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House (text)

    Introduced in House · EN · 28 April 2020

    ViewDownloadOpen at official source

  • Introduced in House (PDF)

    Introduced in House · EN · 28 April 2020

    ViewDownloadOpen at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House

    summary · EN · 28 April 2020

    Open at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

Related records

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.